TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31498862

Group type: EXPERIMENTAL
Intervention: Papaverine injection (0.1 or 0.2 cc)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (routine AVF construction without papaverine injection)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Papaverine injection
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110
Study: 27634557

Group type: EXPERIMENTAL
Intervention: Beta-blocker treatment
Number of subjects: 2906

Group type: COMPARATOR
Intervention: No beta-blocker treatment
Number of subjects: 2906
Study: 25942487

Group type: EXPERIMENTAL
Intervention: Grape-wine extract
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Grape juice extract
Number of subjects: 60
Study: 24944264

Group type: EXPERIMENTAL
Intervention: Progesterone treatment
Number of subjects: 294

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 294
Study: 22612887

Group type: EXPERIMENTAL
Intervention: 155°F blankets
Number of subjects: 156

Group type: COMPARATOR
Intervention: 110°F blankets
Number of subjects: 156
Study: 19171333

Group type: EXPERIMENTAL
Intervention: prolonged GnRHa (depot leuprolide acetate 3.75 mg every 28 days for three doses)
Number of subjects: 36

Group type: COMPARATOR
Intervention: integrin-positive controls (no GnRHa)
Number of subjects: 36

Group type: COMPARATOR
Intervention: integrin-negative controls (no GnRHa)
Number of subjects: 36
Study: 16716615

Group type: EXPERIMENTAL
Intervention: memantine (20-30 mg daily, n=10)
Number of subjects: 19

Group type: COMPARATOR
Intervention: placebo (n=9)
Number of subjects: 19
Study: 16181212

Group type: EXPERIMENTAL
Intervention: PCT platelets (PLTs)
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: PCT plasma
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: PCT PLTs or PCT plasma
Number of subjects: 523
Study: 11932365

Group type: EXPERIMENTAL
Intervention: Balloon dilation for 30 seconds (group I)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Balloon dilation for 180 seconds (group II)
Number of subjects: 74
Study: 9806659

Group type: EXPERIMENTAL
Intervention: Prostatic intraepithelial neoplasia (PIN)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Prostate carcinoma
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: PIN at D18S34 (18q12.2‐12.3)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Multiple foci of PIN
Number of subjects: 52

Group type: COMPARATOR
Intervention: Multiple foci of prostate carcinoma
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Allelic imbalance in matched PIN and prostate carcinoma foci
Number of subjects: 52
Study: 7622644

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Astemizole 10 mg
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 2385207

Group type: EXPERIMENTAL
Intervention: Preoperative intravenous infusion of 10 mg of Propionibacterium avidum KP-40
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative re-infusion of Propionibacterium avidum KP-40
Number of subjects: 0
Study: 6156361

Group type: EXPERIMENTAL
Intervention: Minoxidil in combination with propranolol at a dosage ratio of 1:8
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minoxidil in combination with propranolol at dosage ratios of 1:2 and 1:4
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minoxidil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study: 31533934

Group type: EXPERIMENTAL
Intervention: Aerobic physical fitness training
Number of subjects: 200

Group type: COMPARATOR
Intervention: Relaxation sessions (control group)
Number of subjects: 200
Study: 27927282

Group type: EXPERIMENTAL
Intervention: 0.1% sodium hypochlorite (SH1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 0.2% sodium hypochlorite (SH2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 8% Ricinus communis (RC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.85% saline (C)
Number of subjects: 50
Study: 25882910

Group type: EXPERIMENTAL
Intervention: Low-dose LPS (0.4 ng/kg body weight)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 23682628

Group type: EXPERIMENTAL
Intervention: Elective caesarean section at 38 weeks
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Elective caesarean section at 39 weeks
Number of subjects: 1272
Study: 21535913

Group type: EXPERIMENTAL
Intervention: Grass MATA MPL (300-2000 standardized units/injection)
Number of subjects: 1028

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1028
Study: 19415820

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 9624

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 9624
Study: 19243323

Group type: EXPERIMENTAL
Intervention: Desflurane plus remifentanil
Number of subjects: 36

Group type: COMPARATOR
Intervention: Propofol plus remifentanil
Number of subjects: 36
Study: 15705732

Group type: EXPERIMENTAL
Intervention: Isokinetic exercise (IKE)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Isotonic exercise (ITE)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 19
Study: 14727971

Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization (TMR)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Percutaneous myocardial revascularization (PMR) plus medical therapy
Number of subjects: 182

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Direct myocardial revascularization (DMR)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Different devices used for revascularization
Number of subjects: 182
Study: 9475445

Group type: EXPERIMENTAL
Intervention: Home-based intervention (HBI)
Number of subjects: 762

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 762
Study: 8553675

Group type: EXPERIMENTAL
Intervention: Angiotensin II induced hypertension chemotherapy (IHC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: AFM regimen (adriamycin, 5‐fluorouracil, mitomycin) without IHC
Number of subjects: 26
Study: 2508019

Group type: EXPERIMENTAL
Intervention: Flunisolide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate
Number of subjects: 0
Study: 105101

Group type: EXPERIMENTAL
Intervention: Levamisole (150 mg daily for 3 days at the onset of symptoms)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 12715685

Group type: EXPERIMENTAL
Intervention: Nicergoline (Adavin 60 mg/d)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 30541065

Group type: EXPERIMENTAL
Intervention: Losartan 50-100 mg/d
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Fish oil 1,400-2,800 mg/d
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Both Losartan and Fish oil
Number of subjects: 289

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study: 29624542

Group type: EXPERIMENTAL
Intervention: Single-shot epidural block with 0.25% bupivacaine plus 4 mg of morphine (10 mL) combined with general anesthesia.
Number of subjects: 22

Group type: COMPARATOR
Intervention: General anesthesia alone with desflurane, cisatracurium, and any systemic analgesia.
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups (B and G)
Number of subjects: 22
Study: 27388863

Group type: EXPERIMENTAL
Intervention: Simulated error experiences
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard error education (movies)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions (simulated error experiences and movies)
Number of subjects: 0
Study: 24184028

Group type: EXPERIMENTAL
Intervention: Irrigated radiofrequency ablation
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Cox-Maze lesion set
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 150
Study: 22774869

Group type: EXPERIMENTAL
Intervention: Bibliotherapy (self-help book)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 45
Study: 20493481

Group type: EXPERIMENTAL
Intervention: Anesthesiologist-administered sedation (AAS) using propofol-remifentanil (PR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Patient-controlled sedation (PCS) using propofol-remifentanil (PR)
Number of subjects: 50
Study: 17609490

Group type: EXPERIMENTAL
Intervention: Dark chocolate (6.3 g per day containing 30 mg of polyphenols)
Number of subjects: 44

Group type: COMPARATOR
Intervention: White chocolate (matching polyphenol‐free)
Number of subjects: 44
Study: 16186518

Group type: EXPERIMENTAL
Intervention: Cannabis-based medicine (CBM)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 12076905

Group type: EXPERIMENTAL
Intervention: CT angiography using multidetector CT (MDCT)
Number of subjects: 42
Study: 10102459

Group type: EXPERIMENTAL
Intervention: Clinical prediction index for DVT
Number of subjects: 271
Study: 7598064

Group type: EXPERIMENTAL
Intervention: Low-protein diet (1.47 g protein.kg body cell mass‐1.d‐1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Adequate-protein diet (2.94 g protein.kg body cell mass‐1.d‐1)
Number of subjects: 12
Study: 2358927

Group type: EXPERIMENTAL
Intervention: Ender nails
Number of subjects: 149

Group type: COMPARATOR
Intervention: Sliding nail plate
Number of subjects: 149
Study: 689746

Group type: EXPERIMENTAL
Intervention: Antibiotic decontamination with neomycin, polymyxin, bacitracin, and nystatin (Group A)
Number of subjects: 82

Group type: COMPARATOR
Intervention: No decontamination, isolated (Group B)
Number of subjects: 82

Group type: COMPARATOR
Intervention: No decontamination, treated on the ward (Group C)
Number of subjects: 82
Study: 31469017

Group type: EXPERIMENTAL
Intervention: Ultrasonic debridement plus Shenghong wet dressing
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ultrasonic debridement plus recombinant human fibroblast growth factor (FGF) gel
Number of subjects: 60
Study: 29496253

Group type: EXPERIMENTAL
Intervention: Induction radiochemotherapy followed by consolidation chemotherapy (arm A)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Induction chemotherapy followed by consolidation concurrent radiochemotherapy (arm B)
Number of subjects: 125
Study: 26902765

Group type: EXPERIMENTAL
Intervention: Intravenous administration of 0.5 g meropenem
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intraperitoneal administration of 0.5 g meropenem
Number of subjects: 6
Study: 24961446

Group type: EXPERIMENTAL
Intervention: Educational video on VTE (5 min duration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No video (control group)
Number of subjects: 0
Study: 23082222

Group type: EXPERIMENTAL
Intervention: Computer use for >1 h/day
Number of subjects: 2579

Group type: EXPERIMENTAL
Intervention: Increased computer use by more than 30 min between 2001 and 2007
Number of subjects: 2579

Group type: COMPARATOR
Intervention: TV viewing
Number of subjects: 2579
Study: 20338954

Group type: EXPERIMENTAL
Intervention: Spinal analgesia (bupivacaine 7.5 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: No analgesia
Number of subjects: 64
Study: 17328965

Group type: EXPERIMENTAL
Intervention: IFN‐beta‐1a 30 microg intramuscularly (IM) once‐weekly (qw) (n=8)
Number of subjects: 15

Group type: COMPARATOR
Intervention: IFN‐beta‐1a 44 microg subcutaneously (SC) three‐times‐weekly (tiw) (n=7)
Number of subjects: 15
Study: 16353395

Group type: EXPERIMENTAL
Intervention: i.v. dexamethasone (10 mg in 2 ml)
Number of subjects: 162

Group type: COMPARATOR
Intervention: i.v. placebo (2 ml of normal saline)
Number of subjects: 162
Study: 11432685

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise (3-4 miles jogging 3 times per week) for 10 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ipsapirone (0.3 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: m-CPP (0.4 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Behavioral response to ipsapirone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mean maximal increases of plasma adrenaline and noradrenaline
Number of subjects: 12
Study: 9752300

Group type: EXPERIMENTAL
Intervention: Morphine (M) therapy
Number of subjects: 129

Group type: COMPARATOR
Intervention: No Morphine (M-)
Number of subjects: 129
Study: 8151855

Group type: EXPERIMENTAL
Intervention: Hot humidified air (42-44 degrees C)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Room temperature air (22 degrees C)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 3246253

Group type: EXPERIMENTAL
Intervention: Naloxone (6 mg i.v.)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31291976

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment at 'Wang's Jiaji' acupoints, five times a week for 2 weeks.
Number of subjects: 100

Group type: COMPARATOR
Intervention: 10mg baclofen three times a day for 2 weeks.
Number of subjects: 100
Study: 28365959

Group type: COMPARATOR
Intervention: PPPD with standard lymphadenectomy (N1=30)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PPPD with extended lymphadenectomy (N2=30)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cox regression analysis
Number of subjects: 60
Study: 26242858

Group type: EXPERIMENTAL
Intervention: Publication of British Society for Rheumatology guidelines in 2006
Number of subjects: 11772

Group type: COMPARATOR
Intervention: Pre-guidelines prescribing trend
Number of subjects: 11772

Group type: EXPERIMENTAL
Intervention: Post-guidelines prescribing trend
Number of subjects: 11772
Study: 23282123

Group type: EXPERIMENTAL
Intervention: Aliskiren 150 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Telmisartan 40 mg
Number of subjects: 0
Study: 21481442

Group type: EXPERIMENTAL
Intervention: Ecallantide (30 mg subcutaneous)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19690559

Group type: EXPERIMENTAL
Intervention: Metformin continued after switching to insulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin therapy
Number of subjects: 0
Study: 17054883

Group type: EXPERIMENTAL
Intervention: Foot-specific analysis methods using a three-segment model for gait analysis
Number of subjects: 20
Study: 12751337

Group type: EXPERIMENTAL
Intervention: Peak aerobic exercise (5 minutes at 90%)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prolonged submaximal exercise (2 hours at 60%)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Resistance exercise (3 sets of 10 repetitions at 60 to 70% of 1-RM)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Seated control (5 hours)
Number of subjects: 8
Study: 11093927

Group type: EXPERIMENTAL
Intervention: DIU (diuretic administration; Novotriamazide; 100 mg triamterene and 50 mg hydrochlorothiazide)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: DIU
Number of subjects: 10

Group type: COMPARATOR
Intervention: CON (placebo)
Number of subjects: 10

Group type: COMPARATOR
Intervention: CON
Number of subjects: 10
Study: 9028776

Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sequential Japanese sentences (speech)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Japanese sentences played backward (reversed speech)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Silence
Number of subjects: 12
Study: 8174724

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (LA) 2 mg SC
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: hCG 10,000 IU IM
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both LA and hCG
Number of subjects: 21
Study: 3371847

Group type: EXPERIMENTAL
Intervention: Human leukocyte interferon (a‐IFN) treatment at a standard i.m. dose of 0.7‐1.0 X 10(5)/kg/day for 28 consecutive days, followed by the same dose twice a week for two months.
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 28
Study: 29582896

Group type: EXPERIMENTAL
Intervention: Prefrailty (defined as exhibiting one or two of the five Fried criteria)
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Components of the Fried criteria (slow gait speed and loss of activity)
Number of subjects: 447

Group type: COMPARATOR
Intervention: Robust individuals (control group)
Number of subjects: 447
Study: 27550552

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I) delivered by nonclinician sleep coaches
Number of subjects: 159

Group type: COMPARATOR
Intervention: General sleep education (Control)
Number of subjects: 159
Study: 25686383

Group type: EXPERIMENTAL
Intervention: New leaflet
Number of subjects: 792

Group type: COMPARATOR
Intervention: Old leaflet
Number of subjects: 792

Group type: EXPERIMENTAL
Intervention: Both leaflets
Number of subjects: 792
Study: 24429245

Group type: EXPERIMENTAL
Intervention: Health-care worker instruction
Number of subjects: 481

Group type: COMPARATOR
Intervention: Induction
Number of subjects: 481
Study: 19347247

Group type: EXPERIMENTAL
Intervention: 42 g of protein supplement (SUP) ingested pre- and post-exercise
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both groups (SUP and PL)
Number of subjects: 15
Study: 17522599

Group type: EXPERIMENTAL
Intervention: rye bread with sunflower seeds (SU)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: rye bread with flaxseeds (FL)
Number of subjects: 11

Group type: COMPARATOR
Intervention: rye bread
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: low extraction rate rye bread with SU and FL
Number of subjects: 11
Study: 16680464

Group type: EXPERIMENTAL
Intervention: Doppler ultrasonography measuring angle-corrected time-averaged flow velocity and cross-sectional area of common hepatic artery and portal vein in women with severe preeclampsia
Number of subjects: 58

Group type: COMPARATOR
Intervention: Doppler ultrasonography measuring angle-corrected time-averaged flow velocity and cross-sectional area of common hepatic artery and portal vein in healthy pregnant controls
Number of subjects: 58
Study: 11948038

Group type: EXPERIMENTAL
Intervention: Ramp protocol
Number of subjects: 22

Group type: COMPARATOR
Intervention: 1-min step protocol
Number of subjects: 22
Study: 9771302

Group type: EXPERIMENTAL
Intervention: Remifentanil with isoflurane (Group I, n = 115)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Propofol (Group P, n = 118)
Number of subjects: 251
Study: 7622080

Group type: EXPERIMENTAL
Intervention: Citicoline (1000 mg i.m. daily for 15 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 1978467

Group type: EXPERIMENTAL
Intervention: Remoxipride (mean daily dose 353 mg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Haloperidol (mean daily dose 11 mg)
Number of subjects: 72
Study: 609193

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (200 mg i.m. weekly)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 37
Study: 6279347

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TCS) applied over the site of pain
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TCS) applied over major nerve trunks proximally
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TCS)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Implanted electrodes for prolonged stimulation of damaged peripheral nerves
Number of subjects: 700
Study: 30740767

Group type: EXPERIMENTAL
Intervention: Support for New Mums smartphone application for 6 weeks post birth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standardized institutional postnatal care services
Number of subjects: 0
Study: 29185134

Group type: EXPERIMENTAL
Intervention: PBMT before + PBMT after
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo before + placebo after
Number of subjects: 77
Study: 27090485

Group type: EXPERIMENTAL
Intervention: 12 weeks of progressive high-load power training, 2 sessions per week
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (no interventions)
Number of subjects: 37
Study: 24476226

Group type: EXPERIMENTAL
Intervention: Swaddling
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Heel warming
Number of subjects: 25
Study: 22480275

Group type: EXPERIMENTAL
Intervention: Expression-study group (n = 16)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Structural-study group (n = 14)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (combined results)
Number of subjects: 30
Study: 18616837

Group type: EXPERIMENTAL
Intervention: Remote Food Photography Method (RFPM)
Number of subjects: 52
Study: 17430382

Group type: EXPERIMENTAL
Intervention: Catheter-assisted vein sclerotherapy (KAVS) using foamed polidocanol
Number of subjects: 30
Study: 16354469

Group type: EXPERIMENTAL
Intervention: 400 mg of ofloxacin plus 600 mg of rifampicin (OR, n = 41)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 200 mg of doxycycline plus 600 mg of rifampicin (DR, n = 45)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 1g intramuscularly streptomycin plus 200 mg doxycycline (DS, n = 32)
Number of subjects: 118
Study: 12194667

Group type: EXPERIMENTAL
Intervention: Water-activated bonding material
Number of subjects: 25

Group type: COMPARATOR
Intervention: Composite resin
Number of subjects: 25
Study: 9855438

Group type: EXPERIMENTAL
Intervention: Combination vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Separately administered components
Number of subjects: 0
Study: 7715294

Group type: EXPERIMENTAL
Intervention: Saquinavir 25 mg three times daily
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Saquinavir 75 mg three times daily
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Saquinavir 200 mg three times daily
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Saquinavir 600 mg three times daily
Number of subjects: 49
Study: 2655818

Group type: EXPERIMENTAL
Intervention: Biofragmentable anastomosis ring (BAR)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Sutured anastomosis
Number of subjects: 202

Group type: COMPARATOR
Intervention: Stapled anastomosis
Number of subjects: 202
Study: 1013853

Group type: EXPERIMENTAL
Intervention: Povidone-iodine douche and gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other methods of vaginal preparation
Number of subjects: 0